Wednesday, January 23, 2013

Caregivers' attitudes critical in Alzheimer's disease progression




Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses adm



inistrators, social workers and other health care  professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Deseret News

— Utah is making some headway in Alzheimer's research, finding that caregivers can do more to slow the progression of the disease than previously thought.
New results from Utah State University's Cache County Dementia Progression Study show that how constructively caregivers approach the problems generated by Alzheimer's and other forms of dementia can promote higher functioning among those who suffer.
"This study is a groundbreaking event in the fight against dementia, including Alzheimer's, which has been so pervasively devastating for individuals and families, especially given the limited treatment options for patients and their families," said JoAnn Tschanz, psychology professor at USU and lead author on the study.
"Except for psychiatric symptoms, few studies have examined how caregiver characteristics affect the rate of dementia progression, and our findings indicate significant associations between caregiver coping strategies and the rate of cognitive and functional decline in dementia," Tschanz said.
Coincidentally, University of Utah researchers are on the cusp of developing a smartphone and tablet computer application that will help caregivers know how to handle specific situations, perhaps lending a hand to better coping strategies.
Salt Lake City's Leonard Romney tries to stay busy with his wife, Kathryn, who, at 70, has dealt with an Alzheimer's disease diagnosis for 3½ years. Looking back, however, he said they can pinpoint signs of the disease as early as 2003.
Alzheimer's, as usual, has been a gradual intruder on the couple's lives, but they still are able to spend quite a bit of time together. He tries to make it as positive an experience as possible.
They read, paint, exercise, travel the world and attend ballroom dance sessions together, among other daily household tasks.
Leonard Romney, 73, said it keeps them both happy amid the challenges of a slowly debilitating disease.
"The way Alzheimer's destroys is that it just nibbles bit by bit by bit over a long period of time," he said. "Day to day, you don't see changes. It takes minor adjustments. Over a period of time, the caregiver has to take over virtually all of the necessary tasks of the home."
The biggest issue he's faced is sensing his own shortcomings in dealing with the pressures of being a caregiver. For help, he attends support groups and stays in contact with a number of people also dealing with Alzheimer's in their own families.
"You have to be patient and kind and careful in what you say," Leonard Romney said. "It is a high-pressure professional calling that has been good most of the time."
Alzheimer's disease and related dementia affect one in eight people over age 65 in the United States, according to the Alzheimer's Association. With a growing population, increasing life expectancy and an influx of people moving to Utah, a shortage of caregivers is a main concern for the coming years.
Utah has the highest prevalence of Alzheimer's in the nation, as well as a 127 percent projected growth rate for the next 12 years, according to the state action plan for the disease, which was published in 2012.
The plan states that families provide almost 80 percent of care for Utahns living with the disease, estimated to be worth $1.8 billion annually. The state also incurs huge costs in managing the complexities of dementia. With the proper support, families could help save the bottom line, as well as cope better with family members with the disease.
"The caregiver has a huge influence on the person with dementia," Tschanz said, adding that it is often the caregiver who plans out each day

Monday, January 21, 2013

Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease




Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

ClinicalTrials.gov

This is a 24 week study with 14 visits to the research clinic. Approximately 6 of these visits may be done by phone. Additional phone checks are scheduled at the beginning of each 12 week part of the study. Participants will have a 50:50 chance of being on prazosin or placebo in the first 12 weeks of the study. For the second 12 weeks, all participants will take prazosin.
Study visits include a physical and neurological exam; memory testing; interviews with the caregiver about behaviors; and vital signs.
  Eligibility
Genders Eligible for Study:  Both
Accepts Healthy Volunteers:  No
Criteria
Inclusion Criteria:
  • No age limit
  • Probable or Possible Alzheimer's Disease
  • Disruptive agitated behaviors at least twice a week (overly anxious or excited, making offensive comments.....)
  • Stable medications for 2 weeks
  • Must have a caregiver who spends 10 hours per week caring for the participant and agrees to participate in all evaluation sessions
Exclusion Criteria:
  • Cardiovascular: unstable angina, recent myocardial infarction, preexisting hypotension (systolic BP less than 110) or orthostatic hypotension (≥20 mmHg drop in systolic BP following 2 minutes of standing posture)
  • Any unstable medical condition
  • Exclusionary medications: current treatment with prazosin, other alpha-1 blockers (trazodone, sildenafil, vardenafil or tadalafil)
  • Psychoactive medications: subjects may be psychoactive medication-free or be partial responders (by subjective assessment of referring health care professional) to one psychoactive medication from any of the following classes: antipsychotics, anticonvulsants, mood stabilizers, antidepressants, benzodiazepines, or buspirone. Partial response is defined as some improvement in agitated behavior but persistence of agitated behaviors severe enough to cause patient distress and/or difficulty with caregiving. Although not formally rated, this improvement is equivalent to a Clinical Global Impression of Change rating of no more than minimal improvement (improvement is noticed by not enough to improve patient function or caregiver's practical management of the patient).
  • Psychiatric/behavioral: lifetime schizophrenia; current delirium, mania, depression, or uncontrolled persistent distressing psychotic symptoms (hallucinations, delusions), substance abuse, panic disorder, or any behavior which poses an immediate danger to patient or others or which results in the patient being too uncooperative to meet the requirements of study participation.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01126099
Contacts
Contact: Lucy Wang, MD(206) 277-5089wanglucy@u.washington.edu
Contact: Kirsten Rohde, RN(206) 764-2713kirsten.rohde@va.gov

Saturday, January 19, 2013

Nutricia introduces OTC product for dietary management of Alzheimer's disease



Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

PR WIRE

Nutricia has launched an over the counter (OTC) product for the dietary management of early Alzheimer's disease.
Featuring vanilla and strawberry flavors, Souvenaid product is a 125ml once-a-day drink, which includes a combination of nutrients that are naturally present in food.
People living with Alzheimer's disease have been shown to have relatively low levels of combined nutrients in their bodies despite eating a normal diet, according to the company.
The nutrients, which are included in the product useful for maintaining dietary levels, include omega-3 polyunsaturated fatty acids (docosahexaenoic acid (DHA), eicosapentaenoic acid [EPA]), uridine (as uridine monophosphate [UMP]) and choline, together with phospholipids and B vitamins.
Before the use, people with early Alzheimer's disease must speak with a doctor, specialist nurse, dietician or pharmacist to see if Souvenaid is right for them.

Thursday, January 17, 2013

Major Step Toward an Alzheimer's Vaccine



Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Science News

A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This major breakthrough, details of which are presented January 15 in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer's disease and a vaccine to prevent the illness

One of the main characteristics of Alzheimer's disease is the production in the brain of a toxic molecule known as amyloid beta. Microglial cells, the nervous system's defenders, are unable to eliminate this substance, which forms deposits called senile plaques.
The team led by Dr. Serge Rivest, professor at Université Laval's Faculty of Medicine and researcher at the CHU de Québec research center, identified a molecule that stimulates the activity of the brain's immune cells. The molecule, known as MPL (monophosphoryl lipid A), has been used extensively as a vaccine adjuvant by GSK for many years, and its safety is well established.
In mice with Alzheimer's symptoms, weekly injections of MPL over a twelve-week period eliminated up to 80% of senile plaques. In addition, tests measuring the mice's ability to learn new tasks showed significant improvement in cognitive function over the same period.
The researchers see two potential uses for MPL. It could be administered by intramuscular injection to people with Alzheimer's disease to slow the progression of the illness. It could also be incorporated into a vaccine designed to stimulate the production of antibodies against amyloid beta. "The vaccine could be given to people who already have the disease to stimulate their natural immunity," said Serge Rivest. "It could also be administered as a preventive measure to people with risk factors for Alzheimer's disease."
"When our team started working on Alzheimer's disease a decade ago, our goal was to develop better treatment for Alzheimer's patients," explained Professor Rivest. "With the discovery announced today, I think we're close to  our objective."

Tuesday, January 15, 2013

Train your caregivers faster, easier and more cost-effectively... online



Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

aQuire Training Specialist Brett Brokaw will show you how aQuire's online training can give you the comprehensive training your staff and caregivers will rave about. If you have compliance needs or just need consistent training, you won't want to miss this webinar.

Brett Brokaw
Training Specialist

Join us Tuesday, Jan 15, 2013 11:00 AM - 11:30 PM PST 
as Brett walks you through the aQuire library of courses, our automated management-level reports and our Training Tracker module that gives you instant feedback on your caregiver's training progress.

If you're looking for cost-effective, engaging training options that will meet all your compliance and caregiver training needs, then REGISTER NOW to participate in this important webinar.  

Sunday, January 13, 2013

Boost brain fitness to prevent dementia



Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

UPI.com

In January, many focus on physical fitness, but a U.S. aging expert says effort should be also made to boost mental fitness to prevent dementia.

Dr.Paul Nussbaum, director of brain health for Emeritus Senior Living and clinical neuropsychologist and adjunct professor of neurological surgery at the University of Pittsburgh School of Medicine, said statistics about Alzheimer's disease are alarming, but they demonstrated how crucial it is to adopt a brain fitness program.
"Walking daily, dancing and other forms of aerobic activity help blood flow to the brain," Nussbaum said in a statement. "Fruit and vegetables are beneficial for cognitive health. So are foods rich in Omega 3 fatty acids, such as certain fish and nuts, and antioxidants, which are foods containing vitamins A, C or E."

In addition to physical fitness and healthy diet, Nussbaum said three other practices could have a positive impact on the brain:
-- Socialization: Make an effort to connect and spend time with other people, in person rather than virtually. Research shows isolation and loneliness increase the risk of developing dementia.
-- Mental stimulation: Engage in mental activities that aren't initially easy for you, whether it's learning a new language, taking up Scrabble or other pastime not tried before. Doing so will stimulate the cortex and build brain reserve.
-- Spirituality: Research suggests stress, which has been shown to adversely affect animal brains, is also detrimental to humans. It's important to slow down and take the time to engage in spirituality in the way most comfortable, whether daily prayer, regular formal worship or by meditating and reflecting.

Friday, January 11, 2013

Detrimental Effect of Obesity On Lesions Associated With Alzheimer's Disease

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

ScienceDaily

Science News
 
Researchers from Inserm and the Université Lille/Université Lille Nord de France have recently used a neurodegeneration model of Alzheimer's disease to provide experimental evidence of the relationship between obesity and disorders linked to the tau protein.


This research was conducted on mice and is published in theDiabetes review: it corroborates the theory that metabolic anomalies contribute massively to the development of dementia.
In France, more than 860,000 people suffer from Alzheimer's disease and related disorders, making them the largest cause of age-related loss of intellectual function. Cognitive impairments observed in Alzheimer's disease result from the accumulation of abnormal tau proteins in nerve cells undergoing degeneration (see the picture below). We know that obesity, a major risk factor in the development of insulin resistance and type 2 diabetes, increases the risk of dementia during the aging process. However, the effects of obesity on 'Taupathies' (i.e. tau protein-related disorders), including Alzheimer's disease, were not clearly understood. In particular, researchers assumed that insulin resistance played a major role in terms of the effects of obesity.
The "" team from mixed research unit 837 (Inserm/Université Lille 2/Université Lille Nord de France) directed by Dr. Luc Buée, in collaboration with mixed research unit 1011 "Nuclear receptors, cardiovascular diseases and diabetes," have just demonstrated, in mice, that obese subjects develop aggravated disorders. To achieve this result, young transgenic mice, who develop tau-related neurodegeneration progressively with age, were put on a high-fat diet for five months, leading to progressive obesity.
"At the end of this diet, the obese mice had developed an aggravated disorder both from the point of view of memory and modifications to the Tau protein," explains David Blum, in charge of research at Inserm.
This study uses a neurodenegeneration model of Alzheimer's disease to provide experimental evidence of the relationship between obesity and disorders linked to the tau protein. Furthermore, it indicates that insulin resistance is not the aggravating factor, as was suggested in previous studies.
"Our research supports the theory that environmental factors contribute massively to the development of this neurodegenerative disorder" underlines the researcher. "Our work is now focussing on identifying the factors responsible for this aggravation" he adds.
This research was supported by LabEx DISTALZ (development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease) within the framework of future investments.
Share this story on Facebook, Twitter, and Google:

Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info